A deep and multi-variable analysis of patients with serious Covid-19 respiratory symptoms finds the condition associated with abnormal expression of one gene. . . . → Read More: AI Analysis Finds Serious Covid-19 Genetic Driver
|
|||||
       
  |
An international consortium is seeking teams of scientists using algorithms to design new therapeutic antibodies, to form and fund a start-up company. . . . → Read More: AI-Designed Antibodies for Start-Up Sought in Open Call 
A venture capital company raised €472 million ($US 548 million) for investments in life science and medical device start-ups in Europe. . . . → Read More: European Life Science Venture Fund Raises €472M 
A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes. . . . → Read More: Crispr Licensed for Eye Disease Gene Therapies  Comments are closed  Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, equity, Europe, genomics, investment, licensing, life sciences, pharmaceuticals 
A biomedical engineering team transplanted into a lab rat synthetic tissue with blood vessels made by three-dimensional printing. . . . → Read More: Lab Demonstrates 3-D Printed Tissue, Blood Vessel Implant Comments are closed New products biomedical, biotechnology, engineering, Israel, life sciences, materials science, medical device, physical sciences, university 
NBI, an indicator of investor sentiment in the industry, continued its choppy climb through most of the third quarter, only to start another decline in late September. . . . → Read More: Infographic – Cruising Biotech Index Takes Late Dip 
The Food and Drug Administration stopped a company’s clinical trials of off-the-shelf engineered T-cells after a patient showed an abnormal chromosomal reaction. . . . → Read More: FDA Halts Off-the-Shelf T-Cell Cancer Trials Comments are closed New products, Regulations biomedical, biotechnology, cancer, clinical trials, FDA, genomics, life sciences, NIH, pharmaceuticals 
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science. . . . → Read More: Precision Neuroscience Company Starts-Up, Raises $500M One comment - (Comments are closed) Finance, Joint ventures/collaborations, New products biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, psychiatric, university, venture capital 
A biotechnology enterprise and company aiming to make drugs at lower prices are collaborating on new lower-cost synthetic protein drugs. . . . → Read More: Partnership Seeks Lower-Cost Protein Drugs Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, cancer, economics, life sciences, mathematics, pharmaceuticals, physical sciences 
A venture capital company specializing in financing start-up enterprises at their earliest stages says it raised $450 million for its third venture fund. . . . → Read More: Seed Stage Investors Raise $450M for New Fund Comments are closed Finance biotechnology, computer science, engineering, entrepreneurs, equity, investment, Israel, life sciences, physical sciences, software, venture capital |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
